( TAMPA Fla.--(BUSINESS WIRE)--Mar 7 20...)Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology,Health

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - Accentia Biopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology from February 23 - 27, 2007 in San Diego, CA. The posters discussed findings from a survey of 202 otolaryngologists (ENTs) and allergists in the U.S., U.K., France, and Germany on the burden of chronic sinusitis (CS), the knowledge and attitudes of the fungal etiology of CS, and the differences in treatment practices of CS in the U.S. and Europe.

The first poster, entitled "U.S. and European Perspective on the Burden of Chronic Sinusitis: Survey of Allergists and Otolaryngologists" by Katz, et al., provided results showing that respondents see and treat 45 adult CS patients on average (highest, 80 U.S.; lowest, 21 France) in a typical month, and that ENTs treat about two times more CS patients per month than do allergists, with about one-third (34%) of the patients being surgery refractory. Respondents were generally unhappy with current treatments (86%), wished for more options to treat the surgery refractory population (86%), and for a treatment proven safe and efficacious (91%). Across countries and specialties, respondents agreed that those patients with CS refractory to surgery, suffer from a severe and debilitating condition (88%).

The second poster, entitled "Fungal Etiology of Chronic Sinusitis: Knowledge and Attitudes Survey in the U.S. and Europe" by Stergiou, et al., provided results showing that 71.2% of U.S. and 63.8% of European physicians reported that strong evidence has recently been substantiated to support a fungal etiology to CS. Additionally, 74.9% of the U.S. and 75.4% of European physicians agreed that there was a fungal etiology to CS. The majority of U.S. respondents (83.6%) agreed that surgery refractory CS patients are one subpopulation where a fungal etiology is more likely while 7
'"/>

Page: 1 2 3 4 5
Related medicine technology :

1. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
6. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
7. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
8. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
9. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
10. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
11. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions